Landmark Papers in Cardiovascular Medicine provides a thorough and wide-ranging analysis of core examples of novel research, clinical trials and seminal papers published in the medical literature that have paved the way for breakthroughs in the management of the entire spectrum of cardiovascular disease.
These papers may have produced positive, negative or equivocal findings but are regarded by the experts as having either stimulated a paradigm shift in therapeutic strategy or been the catalyst for new and improved methods of research, diagnosis or drug development. Our aim is to provide both a benchmark and inspiration for future work in the field of cardiovascular medicine and also to give the reader an insight into the mechanics and infrastructure of how high-quality evidence-based medicine
has been produced.
Each trial summary is punctuated by sections on ‘strengths and limitations’, ‘impact on the field’, ‘learning points’ and ‘further reading’ suggestions that allow for a completely holistic analysis of the data. The experts also give their views on what research is currently underway, their hopes for the future and what advances they predict will occur in each subspecialty field of cardiovascular medicine, making this book essential reading for all those individuals with an interest in the field.
About the Author
Dr Aung Myat is currently a BHF Clinical Research Training Fellow in Coronary Physiology working in The Rayne Institute at St Thomas’ Hospital, King’s College London. He is a Specialist Registrar in the West Midlands Deanery Cardiology Training Programme but has taken time out of formal training to undertake a postgraduate PhD degree.
Tony Gershlick is Consultant Cardiologist at Universtiy Hospitals of Leicester, and has a personal chair as Professor of Interventional Cardiology, University of Leicester. He received his BSc in Pharmacological Biochemistry at St Mary’s Hospital and then went on train in London for MB BS, MRCP, and junior cardiology training at the London and London Chest Hospitals
Professor Gershlick is Chairman, R&D Committee for the British Cardiovascular Intervention Society. He is also part of the BCIS Audit Group, and since 1995 he has been a Council Member with BCIS with special responsibilities for research.
Read more about: